Megan Feldmann, OTR/L | |
313 S 5th St, Odessa, DE 19730-2078 | |
(302) 376-4128 | |
Not Available |
Full Name | Megan Feldmann |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 313 S 5th St, Odessa, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073164992 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | U1-0002076 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Megan Feldmann, OTR/L 313 S 5th St, Odessa, DE 19730-2078 Ph: () - | Megan Feldmann, OTR/L 313 S 5th St, Odessa, DE 19730-2078 Ph: (302) 376-4128 |
News Archive
Using a combination of polymers that respond to temperature, a research team at the University of Utah has developed a multifunctional nanoparticle that can image tumors using ultrasound and simultaneously deliver cell-damaging energy and anticancer drugs to those tumors. In addition, these nanoparticles appear to act specifically on tumors and not on healthy tissue.
Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec for initiating the investigational new drug (IND)-supporting studies of ISIS-BIIB4 Rx.
RegeneRx Biopharmaceuticals, Inc. nnounced that scientists have identified a long sought-after extracellular signaling pathway and receptor for thymosin beta 4 (Tβ4). The observation that Tβ4 increases cell surface ATP (energy produced by cells), could explain its ability to protect and regenerate tissue after ischemic injury and hypoxia (oxygen deficiency).
Patients with diabetes mellitus experience significantly higher rates of surgical and systemic complications, higher mortality and increased length of stay during hospitalization following 11 major elective procedures, according to research presented today at the American Association of Clinical Endocrinologists (AACE) 21st Annual Meeting & Clinical Congress in Philadelphia.
Among the devastating complications of severe or critical coronavirus disease 2019 (COVID-19), clot formation ranks high in the adverse impact it creates. An important question is whether SARS-CoV-2-spike-based vaccines also cause such coagulopathies. A new study, released as a preprint on the medRxiv* server, examines this risk for the first time.
› Verified 4 days ago
Brandi Moore, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Odessa, DE 19730 Phone: 302-376-4128 | |
Lyndsey Fraser, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Odessa, DE 19730 Phone: 302-378-5010 | |
Margaret Capelli, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Box 4010, Odessa, DE 19730 Phone: 302-376-4128 | |
Peter Thistle, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Odessa, DE 19730 Phone: 302-376-4128 | |
Lacie Lynn Craft, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Odessa, DE 19730 Phone: 302-388-8636 | |
Christiana Onimus, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Odessa, DE 19730 Phone: 302-378-5010 |